InvestorLens

AMGN — AMGEN INC

Health Care · Drug Manufacturers

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying AMGN?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
60
Institutional Conviction
Net distribution · 3 buying vs 2 selling last quarter
43
Macro Tailwind
Macro conditions are mixed for this sector
53
Congressional Activity
1 congressional purchase, 2 sales disclosed in the last 6 months
Why? — Evidence & Confidence ▾

Of 5 tracked investors who changed their AMGN position last quarter, 3 bought and 2 sold (60% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 1 congressional purchase, 2 sales disclosed in the last 6 months.

Supporting evidence
  • +3 tracked investors added or increased positions last quarter (Ken Griffin, Ray Dalio, Paul Tudor Jones)
  • +5 tracked investors reported holding AMGN at their latest filing
Contradicting evidence — always shown
  • −2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
  • −Congressional disclosures lean toward selling (2 sales vs 1 purchases, 6 months)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About AMGEN INC (AMGN)

AMGEN INC (AMGN) appears in the most recent 13F filings of 5 tracked institutional investors. AMGEN INC is classified in the Health Care sector (Drug Manufacturers industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $894M. Across recent filings, tracked investors recorded 9 new positions, 16 increased, 20 reduced, and 5 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in AMGN

50
/100
Mixed Activity
Added / Increased25
Reduced20
Exited5
BearishBullish
Crowded Trade Score™

How many top investors track AMGN

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

AMGN Ownership Composition

How AMGEN INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
93% of tracked value
Institutions
5
tracked investors
Total Reported
$1.2B
combined 13F value
Types2
  • Multi-Strategy / Quant92.5%
  • Macro7.5%
Multi-Strategy / Quant(3)
92.5%
Macro(2)
7.5%

Tracked investors currently reporting AMGN

1 tracked investor has since exited this position — listed separately below.

  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    2.5M
    Value
    $894.2M
    % Portfolio
    0.10%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    483.2K
    Value
    $175M
    % Portfolio
    0.06%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    218.1K
    Value
    $79M
    % Portfolio
    0.11%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    26.4K
    Value
    $9.6M
    % Portfolio
    0.01%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    21.9K
    Value
    $7.9M
    % Portfolio
    0.03%

Previously held AMGN

These investors reported AMGN in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Cathie WoodARK Investment Management57.9K$16.2MJun 30, 2025

Recent activity

Frequently asked questions

How many institutional investors hold AMGN?
5 tracked institutional investors disclosed a position in AMGN (AMGEN INC) in their most recent 13F filing.
Who is the largest institutional holder of AMGN?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in AMGN, valued at $894M.
Did institutional ownership of AMGN increase or decrease?
Across recent 13F filings, tracked investors recorded 9 new positions, 16 increased, 20 reduced, and 5 fully exited AMGN.
What sector is AMGN in?
AMGEN INC is classified in the Health Care GICS sector, Drug Manufacturers industry.
Where does this AMGN ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.